What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
– This…
Continue Reading
What You Should Know:
Data Driven Insights Enabled by Merck and Amgen Fundings
As the most extensive repository of its kind, this data lake empowers biopharmaceutical companies by providing crucial insights necessary for advancing diagnostic and…
Continue Reading
What You Should Know:
– AstraZeneca, a global biopharmaceutical company, has announced the launch of Evinova, a new business venture dedicated to providing cutting-edge digital health solutions that address the evolving needs of healthcare professionals,…
Continue Reading
What You Should Know:
– 23andMe, a genetic health and biopharmaceutical company launched Health Action Plan, a new digital tool for 23andMe+ members that draws on results from genetic reports, health history survey data, as…
Continue Reading
What You Should Know:
– COTA, a real-world oncology data and analytics company announced the launch of Vista, a large-scale automated EHR dataset to accelerate cancer research and the deployment of trusted generative AI in cancer…
Continue Reading
Health technology company PicnicHealth announced it is moving into the oncology space and teaming up with AstraZeneca to build a registry to generate real-world data on breast cancer. The company says it will work with…
Continue Reading
Sandesh Seth, CEO of Actinium Pharmaceuticals which is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs joins eHealth Radio and…
by Fred Pennic 07/14/2023 Leave a Comment
Versanis logo
What You Should Know:
Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of…
Continue Reading
Stephen Pyke, Chief Clinical Digital and Data Officer, ParexelBy creating efficiencies with technology, CROs have an opportunity to build clinical trials of the future.For many years, artificial intelligence (AI), machine learning (ML) and natural…
Continue Reading
What You Should Know:– In support of Lipoprotein(a) Awareness Day, 23andMe, a human genetics and biopharmaceutical company, today announced a collaboration with Novartis to increase awareness for Lipoprotein(a) (Lp(a)).– High levels of Lp(a) are associated…
Continue Reading
